Moreover, we also observed that FSK treatment reduced cardiac fibrosis in diabetic mice by reducing the expression of FN, collagen I, TGF-β, and α-SMA, suggesting that FSK treatment significantly protects against diabetic cardiomyopathy in the early stage. This evidence concerns the gene TGFB1 and diabetic cardiomyopathy.